ARCHIVE ISSUES – SEPTEMBER 2022

The Journal of Precision Medicine - September 2022

Why Equitable Access in the Treatment of Cancer Depends on Comprehensive Genomic Profiling

Clinical Implications and Utility of Polygenic Risk Scores in Women at Elevated Risk for Breast Cancer

The Almac Clinical Technologies Team on Clinical Trial Design and Execution with their Clients

Integrating Personalized Medicine into Preventive Care through Risk Stratification

Access to Comprehensive Genomic Profiling (ACGP) Coalition

Twenty years of RNA research and diagnostic development… What have we learnt?

Genomic Innovation Democratizes Precision Medicine

The Rise of Predictive Genomics

Prospective Clinicogenomic Program (PCG) at Flatiron

Bringing complexity into clarity with Qlucore Diagnostics: Clinical use of transcriptomic data to classify cancer patients

Clinical Performance and Value Vignettes (CPVs) Decrease Clinical Care Variation, Improve Patient Outcomes, and Decrease Costs

BACK TO ARCHIVE